Balyasny Asset Management’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
Balyasny Asset Management's GDRX Position: Q1 2026 in Review
Balyasny Asset Management reduced its GoodRx Holdings (GDRX) stake by 18% in Q1 2026, selling an estimated $185K and leaving 370,310 shares worth $726K. The position accounts for ﹤0.01% of the portfolio, ranked #2211.
Balyasny Asset Management first reported a position in GDRX in Q2 2023 and has held it in 9 quarters since. The position peaked at $2.36M in Q2 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- Balyasny Asset Management held 370,310 shares of GoodRx Holdings worth $726K as of Q1 2026.
- Balyasny Asset Management sold 78,722 GoodRx Holdings shares in Q1 2026, an estimated $185K.
- GoodRx Holdings made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2211 holding.
- Balyasny Asset Management first reported a position in GoodRx Holdings in Q2 2023 and has held it in 9 quarters since.
- Balyasny Asset Management's GoodRx Holdings position peaked at $2.36M in Q2 2023.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.